Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Takafumi Sugimoto"'
Autor:
Takafumi Sugimoto, Yutaka Yamaji, Kosuke Sakitani, Yoshihiro Isomura, Shuntaro Yoshida, Atsuo Yamada, Yoshihiro Hirata, Keiji Ogura, Makoto Okamoto, Kazuhiko Koike
Publikováno v:
Canadian Journal of Gastroenterology and Hepatology, Vol 29, Iss 6, Pp 321-325 (2015)
BACKGROUND: Endoscopic submucosal dissection (ESD) of early gastric cancer is a minimally invasive procedure. However, the risk for metachronous cancers after successful cancer treatment remains high and the risk factors for metachronous cancers have
Externí odkaz:
https://doaj.org/article/72f571d1abf643ae91010f265433505c
Publikováno v:
Kanzo. 59:545-553
Autor:
Makoto Okamoto, Tomoya Omae, Keigo Matsuo, Nobumi Suzuki, Kazuhiko Koike, Yoshihiro Hirata, Takafumi Sugimoto, Yoku Hayakawa, Goichi Togo, Ryota Niikura, Satoki Shichijo, Noriyuki Takano, Keisuke Fukui, Hirobumi Suzuki, Hirotsugu Watabe, Motoko Seto, Shinzo Yamamoto, Satoshi Mochizuki, Yuri Ito, Atsuo Yamada, Yoshihiro Isomura
Publikováno v:
Journal of Digestive Diseases. 17:670-675
Objective Vonoprazan is a potassium-competitive acid blocker, a new type of acid-suppressing drug, and has recently become available for peptic ulcers, gastroesophageal reflux disease, and Helicobacter pylori (H. pylori) eradication. Its efficacy for
Publikováno v:
SMC
The support vector machine (SVM) for multiclass classification problem has attracted attention in recent years. We focus on the multiobjective multiclass SVM (MMSVM), which maximizes accurately the geometric margins of pairwise classes. The MMSVM was
Autor:
Yutaka Yamaji, Hirotsugu Watabe, Shuntaro Yoshida, Yuka Kobayashi, Yoshihiro Hirata, Takafumi Sugimoto, Kazuhiko Koike, Atsuo Yamada, Yoshitaka Watanabe
Publikováno v:
Journal of Digestive Diseases. 16:649-655
Objective Patients who take drugs regularly are increasing, not least due to metabolic and orthopedic diseases. In the present study we aimed to investigate the association between the use of drugs, such as non-steroidal anti-inflammatory drugs (NSAI
Autor:
Yoshihiro Isomura, Shuntaro Yoshida, Kazuhiko Koike, Yutaka Yamaji, Makoto Okamoto, Kosuke Sakitani, Atsuo Yamada, Yoshihiro Hirata, Takafumi Sugimoto, Keiji Ogura
Publikováno v:
Canadian Journal of Gastroenterology and Hepatology, Vol 29, Iss 6, Pp 321-325 (2015)
BACKGROUND: Endoscopic submucosal dissection (ESD) of early gastric cancer is a minimally invasive procedure. However, the risk for metachronous cancers after successful cancer treatment remains high and the risk factors for metachronous cancers have
Autor:
Satoki, Shichijo, Yoshihiro, Hirata, Ryota, Niikura, Yoku, Hayakawa, Atsuo, Yamada, Satoshi, Mochizuki, Keigo, Matsuo, Yoshihiro, Isomura, Motoko, Seto, Nobumi, Suzuki, Hirobumi, Suzuki, Shinzo, Yamamoto, Takafumi, Sugimoto, Tomoya, Omae, Makoto, Okamoto, Hirotsugu, Watabe, Goichi, Togo, Noriyuki, Takano, Keisuke, Fukui, Yuri, Ito, Kazuhiko, Koike
Publikováno v:
Journal of digestive diseases. 17(10)
Vonoprazan is a potassium-competitive acid blocker, a new type of acid-suppressing drug, and has recently become available for peptic ulcers, gastroesophageal reflux disease, and Helicobacter pylori (H. pylori) eradication. Its efficacy for H. pylori
Autor:
Shuntaro Obi, Shinpei Sato, Miho Kanda, Toshihiro Kawai, Takafumi Sugimoto, Yoko Yashima, Nobuyuki Enomoto, Takahisa Sato
Publikováno v:
World Journal of Surgical Oncology
Background The outcomes of treatment of ruptured varices in patients with hepatocellular carcinoma (HCC) and portal vein tumor thrombus (PVTT) are unclear. We therefore evaluated the long- (rebleeding and death) and short-term (immediate death within
Autor:
Masao Omata, Yutaka Yamaji, Atsuo Yamada, Haruka Kambe, Haruhiko Yoshida, Hirotsugu Watabe, Takafumi Sugimoto, Kazuhiko Koike
Publikováno v:
Journal of Digestive Diseases. 13:374-380
OBJECTIVE: The study was aimed to assess the efficacy of sodium phosphate (NaP) tablets and polyethylene glycol (PEG) on colon cleansing. METHODS: A prospective, randomized trial was conducted at the Graduate School of Medicine, University of Tokyo.
Autor:
Tomoya Ohmae, Yoshihiro Hirata, Masao Akanuma, Yutaka Yamaji, Ayako Yanai, Yuzo Mitsuno, Kazuhiko Koike, Takafumi Sugimoto, Shuntaro Yoshida, Keiji Ogura, Kosuke Sakitani, Yoku Hayakawa, Shin Maeda
Publikováno v:
International Journal of Antimicrobial Agents. 39:352-355
The third-line treatment regimen for Helicobacter pylori after failure of clarithromycin- and metronidazole-based therapies is not yet established. Sitafloxacin (STX) is a quinolone that possesses potent in vitro activity against H. pylori. In this s